Wall Street analysts expect Phibro Animal Health Corporation (NASDAQ:PAHC) to post earnings of $0.36 per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Phibro Animal Health Corporation’s earnings. The lowest EPS estimate is $0.33 and the highest is $0.39. Phibro Animal Health Corporation posted earnings of $0.40 per share during the same quarter last year, which suggests a negative year over year growth rate of 10%. The firm is scheduled to announce its next earnings results after the market closes on Wednesday, August 30th.

According to Zacks, analysts expect that Phibro Animal Health Corporation will report full-year earnings of $1.45 per share for the current fiscal year. For the next fiscal year, analysts expect that the company will post earnings of $1.56 per share, with EPS estimates ranging from $1.45 to $1.62. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that follow Phibro Animal Health Corporation.

Phibro Animal Health Corporation (NASDAQ:PAHC) last issued its quarterly earnings data on Monday, May 8th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.37. Phibro Animal Health Corporation had a return on equity of 54.68% and a net margin of 8.49%. The company had revenue of $190 million for the quarter, compared to the consensus estimate of $185.90 million. During the same quarter last year, the business posted $0.38 earnings per share. The firm’s revenue was up 3.5% compared to the same quarter last year.

PAHC has been the subject of a number of recent research reports. Zacks Investment Research raised shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price objective for the company in a research report on Thursday, May 11th. BidaskClub raised shares of Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 22nd. Piper Jaffray Companies set a $35.00 price objective on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Finally, Credit Suisse Group cut shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and lifted their target price for the company from $29.00 to $36.00 in a research note on Friday, June 2nd. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $30.50.

TRADEMARK VIOLATION NOTICE: “Zacks: Brokerages Anticipate Phibro Animal Health Corporation (PAHC) Will Post Earnings of $0.36 Per Share” was published by American Banking News and is owned by of American Banking News. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://www.americanbankingnews.com/2017/08/11/zacks-brokerages-anticipate-phibro-animal-health-corporation-pahc-will-post-earnings-of-0-36-per-share.html.

Shares of Phibro Animal Health Corporation (NASDAQ PAHC) opened at 39.30 on Friday. The stock has a market cap of $1.56 billion, a P/E ratio of 24.41 and a beta of 1.35. Phibro Animal Health Corporation has a 12 month low of $20.14 and a 12 month high of $39.95. The company has a 50 day moving average price of $37.96 and a 200-day moving average price of $32.15.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Investors of record on Wednesday, September 6th will be paid a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date of this dividend is Friday, September 1st. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is 24.69%.

In related news, insider Jack Bendheim sold 32,000 shares of Phibro Animal Health Corporation stock in a transaction on Thursday, July 6th. The shares were sold at an average price of $36.49, for a total transaction of $1,167,680.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, major shareholder Bfi Co., Llc sold 48,000 shares of Phibro Animal Health Corporation stock in a transaction on Friday, June 30th. The shares were sold at an average price of $37.42, for a total transaction of $1,796,160.00. Following the transaction, the insider now owns 92,000 shares in the company, valued at approximately $3,442,640. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 352,000 shares of company stock worth $12,599,200. 48.09% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Mason Street Advisors LLC boosted its position in Phibro Animal Health Corporation by 7.1% in the first quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock worth $122,000 after buying an additional 286 shares during the period. Victory Capital Management Inc. boosted its position in Phibro Animal Health Corporation by 79.2% in the first quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock worth $129,000 after buying an additional 2,021 shares during the period. State of Alaska Department of Revenue boosted its stake in shares of Phibro Animal Health Corporation by 80.9% in the second quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after buying an additional 1,650 shares during the last quarter. Municipal Employees Retirement System of Michigan boosted its stake in shares of Phibro Animal Health Corporation by 3.6% in the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after buying an additional 150 shares during the last quarter. Finally, KBC Group NV bought a new stake in shares of Phibro Animal Health Corporation during the second quarter valued at approximately $166,000. Institutional investors own 47.41% of the company’s stock.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Get a free copy of the Zacks research report on Phibro Animal Health Corporation (PAHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.